Jason Kneeland
Comptroller/Controller/Auditor presso ACER THERAPEUTICS INC.
Profilo
Jason Kneeland is currently the Vice President-Finance & Controller at Acer Therapeutics, Inc. He previously worked as the Vice President-Finance at TechTarget, Inc. and as a Senior Manager at Corporate Finance Group, Inc. He obtained an undergraduate degree from Johnson & Wales University, Inc.
Posizioni attive di Jason Kneeland
Società | Posizione | Inizio |
---|---|---|
ACER THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
Precedenti posizioni note di Jason Kneeland
Società | Posizione | Fine |
---|---|---|
TECHTARGET, INC. | Corporate Officer/Principal | 01/11/2017 |
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Finance Group, Inc. provides financial consulting services. It offers private equity services, CFO services, consulting, interim management, corporate tax, and valuation. The company was founded by Arnold Tinter, Nicholas Nardone and Shane Caiazzo in 2000 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/08/2013 |
Formazione di Jason Kneeland
Johnson & Wales University, Inc. | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TECHTARGET, INC. | Technology Services |
Aziende private | 2 |
---|---|
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Finance Group, Inc. provides financial consulting services. It offers private equity services, CFO services, consulting, interim management, corporate tax, and valuation. The company was founded by Arnold Tinter, Nicholas Nardone and Shane Caiazzo in 2000 and is headquartered in Boston, MA. | Commercial Services |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- Jason Kneeland